These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34522721)

  • 1. Corrigendum to "SOX4 contributions to TGF-β-induced endothelial-mesenchymal transition and stem cell characteristics of gastric cancer cells" [Genes & Diseases 5 (2018) 49-61].
    Peng X; Liu G; Peng H; Chen A; Zha L; Wang Z
    Genes Dis; 2021 Nov; 8(6):946-948. PubMed ID: 34522721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX4 contributes to TGF-β-induced epithelial-mesenchymal transition and stem cell characteristics of gastric cancer cells.
    Peng X; Liu G; Peng H; Chen A; Zha L; Wang Z
    Genes Dis; 2018 Mar; 5(1):49-61. PubMed ID: 30258935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Sox9 augments BMP2-induced chondrogenic differentiation by downregulating Smad7 in mesenchymal stem cells (MSCs)" [
    Zhao C; Jiang W; Zhou N; Liao J; Yang M; Hu N; Liang X; Xu W; Chen H; Liu W; Shi LL; Oliveira L; Wolf JM; Ho S; Athiviraham A; Tsai HM; He TC; Huang W
    Genes Dis; 2023 Mar; 10(2):624-626. PubMed ID: 37223534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference" [
    Yan S; Zhang R; Wu K; Cui J; Huang S; Ji X; An L; Yuan C; Gong C; Zhang L; Liu W; Feng Y; Zhang B; Dai Z; Shen Y; Wang X; Luo W; Liu B; Haydon RC; Lee MJ; Reid RR; Wolf JM; Shi Q; Luu HH; He TC; Weng Y
    Genes Dis; 2023 Mar; 10(2):632-637. PubMed ID: 37223525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4" [Genes Dis DOI: 10.1016/j.gendis.2020.07.005].
    Shen X; Weng C; Wang Y; Wang C; Feng S; Li X; Li H; Jiang H; Wang H; Chen J
    Genes Dis; 2022 Mar; 9(2):576-577. PubMed ID: 35226709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4" [Genes & Diseases 9(2022) 443-455].
    Shen X; Weng C; Wang Y; Wang C; Feng S; Li X; Li H; Jiang H; Wang H; Chen J
    Genes Dis; 2022 Nov; 9(6):1757-1758. PubMed ID: 36157500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to 'Bmi-1: At the crossroads of physiological and pathological biology' [Genes & Diseases 2 (2015) 225-239].
    Bhattacharya R; Mustafi SB; Street M; Dey A; Dwivedi SKD
    Genes Dis; 2015 Dec; 2(4):353. PubMed ID: 30258874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
    Wang L; Li Y; Yang X; Yuan H; Li X; Qi M; Chang YW; Wang C; Fu W; Yang M; Zhang J; Han B
    Prostate; 2014 May; 74(6):647-58. PubMed ID: 24435928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-30a/SOX4 Double Negative Feedback Loop is modulated by Disulfiram and regulates EMT and Stem Cell-like properties in Breast Cancer.
    Liu Z; Mi M; Zheng X; Zhang C; Zhu F; Liu T; Wu G; Zhang L
    J Cancer; 2021; 12(16):5053-5065. PubMed ID: 34234874
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to 'Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics' [Genes & Diseases 10 (2023) 1367-1401].
    Anand U; Dey A; Singh Chandel AK; Sanyal R; Mishra A; Pandey DK; De Falco V; Upadhyay A; Kandimalla R; Chaudhary A; Dhanjal JK; Dewanjee S; Vallamkondu J; Pérez de la Lastra JM
    Genes Dis; 2024 Jul; 11(4):101211. PubMed ID: 38572324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs)" [Genes & Diseases 5 (2018) 137-149].
    Yu X; Chen L; Wu K; Yan S; Zhang R; Zhao C; Zeng Z; Shu Y; Huang S; Lei J; Ji X; Yuan C; Zhang L; Feng Y; Liu W; Huang B; Zhang B; Luo W; Wang X; Liu B; Haydon RC; Luu HH; He TC; Gan H
    Genes Dis; 2023 Mar; 10(2):630-631. PubMed ID: 37223498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma" [Genes Dis 6(4) 2019 407-418].
    Tang J; Zhang L; Zhou T; Sun Z; Kong L; Jing L; Xing H; Wu H; Liu Y; Zhou S; Li J; Chen M; Xu F; Tang J; Ma T; Hu M; Liu D; Guo J; Zhu X; Chen Y; Ye T; Wang J; Li X; Xing HR
    Genes Dis; 2022 Jan; 9(1):282-284. PubMed ID: 35005124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
    Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
    Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Novel biallelic
    Yang L; Xue X; Zeng T; Chen X; Zhao Q; Tang X; Yang J; An Y; Zhao X
    Genes Dis; 2020 Sep; 7(3):485. PubMed ID: 32885000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance" [Genes Dis 694 (2019) 419-430].
    Wang W; Hu B; Qin JJ; Cheng J; Li X; Rajaei M; Fan J; Yang XR; Zhang R
    Genes Dis; 2020 Mar; 7(1):160-161. PubMed ID: 32181287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism.
    Bin C; Xiaofeng H; Wanzi X
    Exp Lung Res; 2018 Aug; 44(6):280-287. PubMed ID: 30475081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway.
    Li B; Cheng X; Aierken A; Du J; He W; Zhang M; Tan N; Kou Z; Peng S; Jia W; Tang H; Hua J
    Front Cell Dev Biol; 2021; 9():799571. PubMed ID: 34950665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs" [Genes & Diseases 5 (2018) 62-74].
    Zeng Z; Huang B; Huang S; Zhang R; Yan S; Yu X; Shu Y; Zhao C; Lei J; Zhang W; Yang C; Wu K; Wu Y; An L; Ji X; Gong C; Yuan C; Zhang L; Liu W; Feng Y; Zhang B; Dai Z; Shen Y; Wang X; Luo W; Haydon RC; Luu HH; Zhou L; Reid RR; He TC; Wu X
    Genes Dis; 2023 Mar; 10(2):627-629. PubMed ID: 37223508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.